Navigator

      Support By : Li-lab

Drugs And Genes
Negative Drug Target Genes
GENE_SYMBOL DRUG_NAME Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) Potency (nM) AC50 (nM) Datasource
IP6K1 8-amino-6-pyrrolidin-1-yl-3H-quinazolin-4-one NA 189000 NA NA NA NA BindingDB
IP6K2 6-[(E)-2-phenylethenyl]-3H-quinazolin-4-one NA 193000 NA NA NA NA BindingDB
IP6K3 6-pyrrolidin-1-yl-3H-quinazolin-4-one NA 137000 NA NA NA NA BindingDB
IP6K3 6-[(E)-2-phenylethenyl]-3H-quinazolin-4-one NA 168000 NA NA NA NA BindingDB
IRAK1 6-(6-methoxyimidazo[1,2-a]pyridin-3-yl)-N-piperidin-4-ylpyridin-2-amine NA 293000 NA NA NA NA TTD
IRAK1 N-(azetidin-3-yl)-6-(6-chloroimidazo[1,2-a]pyridin-3-yl)pyridin-2-amine NA 195000 NA NA NA NA TTD
IRAK1 6-(6-chloroimidazo[1,2-a]pyridin-3-yl)-N-piperidin-3-ylpyridin-2-amine NA 175000 NA NA NA NA TTD
IRAK1 N-(4-methoxybenzyl)benzofuro[2,3-b]pyridin-4-amine 1000000 NA NA NA NA NA TTD
IRAK3 Pazopanib NA NA 800000 NA NA NA BindingDB
IRAK3 1H-Pyrrole-3-carboxamide, 5-((5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-N-((2S)-2-hydroxy-3-(4-morpholinyl)propyl)-2,4-dimethyl- NA NA 1900000 NA NA NA BindingDB
IRAK3 Mln8054 NA NA 1400000 NA NA NA BindingDB
IRAK3 Gefitinib NA NA 1500000 NA NA NA BindingDB
IRAK3 Canertinib NA NA 3000000 NA NA NA BindingDB
IRAK3 N-[(2R,3S,4S,6S)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide NA NA 180000 NA NA NA BindingDB
IRAK3 Sns-032 NA NA 2900000 NA NA NA BindingDB
IRAK3 Tandutinib NA NA 730000 NA NA NA BindingDB
IRAK3 Sunitinib NA NA 940000 NA NA NA BindingDB
IRAK3 Jnj-7706621 NA NA 3400000 NA NA NA BindingDB
IRAK3 Tozasertib NA NA 5600000 NA NA NA BindingDB
IRAK4 (1R,2S,3R,5R)-3-[[5-(1,3-benzothiazol-2-yl)-2-(cyclobutylamino)pyrimidin-4-yl]amino]-5-(hydroxymethyl)cyclopentane-1,2-diol NA 403000 NA NA NA NA BindingDB|TTD